Sanofi (SNY) Profit After Tax (2009 - 2026)

Sanofi has disclosed Profit After Tax across 18 years of filings, most recently posting $1.9 billion for Q1 2026.

• Profit After Tax for Q1 2026 came in at $1.9 billion, down 4.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.7 billion (up 28.75% YoY), and the FY2025 annual result was $9.1 billion, up 53.98% from the prior year.
• Profit After Tax came in at $1.9 billion for Q1 2026 at Sanofi, up from -$7.7 billion in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $10.1 billion in Q3 2025 to a low of -$7.7 billion in Q4 2025.
• The 5-year median for Profit After Tax is $2.0 billion (2025), against an average of $1.8 billion.
• Peak annual rise in Profit After Tax reached 271.15% in 2025, while the deepest fall reached 1715.95% in 2025.
• Sanofi's Profit After Tax stood at $3.2 billion in 2022, then plunged by 129.83% to -$964.0 million in 2023, then surged by 149.55% to $477.7 million in 2024, then sank by 1715.95% to -$7.7 billion in 2025, then surged by 124.57% to $1.9 billion in 2026.
• The last three Profit After Tax figures came in at $1.9 billion (Q1 2026), -$7.7 billion (Q4 2025), and $10.1 billion (Q3 2025), per Business Quant data.